Status:
RECRUITING
Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
Lung Cancer
Lung Metastases
Eligibility:
All Genders
18+ years
Brief Summary
The role of radiotherapy is well established in the management of early stage lung cancer or as part of a multidisciplinary approach of locally advanced lung cancer (1). Recent advances in Cyberknife...
Eligibility Criteria
Inclusion
- Lung cancer (primary or secondary, any histological type)
- Early stage lung cancer: patients diagnosed with stage I for which operation is contra-indicated, for example because of cardiac or pulmonary comorbidities.
- Locally advanced lung cancer stages II - IIIB
- Metastatic lung cancer stage IV (palliative care)
- 18 y ≤ age ≤ 85 y
Exclusion
- age \<18y
- incapacity of judgment
- Absence of a signed consent form
Key Trial Info
Start Date :
October 10 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04684186
Start Date
October 10 2016
End Date
June 1 2026
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire vaudois - Department of Radiology and Interventional Radiology
Lausanne, Canton of Vaud, Switzerland, 1011